Get started
Author

Angimar Uriepero

Observed names: Angimar Uriepero Palma, Angimar Uriepero-Palma, Uriepero, Angimar
ORCID: 0000-0003-4398-1243
Observed ORCID: 0000-0003-4398-1243
OpenAlex ID: A5007660959
Childhood Vaccine Acceptance and Refusal among Warao Amerindian Caregivers in Venezuela; A Qualitative Approach
2017 · Jochem Burghouts, Berenice Del Nogal, et al. · PLoS ONE · 42
PDF
Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies
2022 · Kamira Maharaj, Angimar Uriepero, et al. · Frontiers in Immunology · 37
PDF
Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia
2019 · Pablo Elías Morande, Mariela Sivina, et al. · Blood · 18
PDF
Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model
2025 · Wael Gamal, Nienke B. Goedhart, et al. · Blood Advances · 13
LPL protein in Chronic Lymphocytic Leukaemia have different origins in Mutated and Unmutated patients. Advances for a new prognostic marker in CLL
2018 · Daniel Prieto, Noé Seija, et al. · British Journal of Haematology · 13
PDF
TGF-β/SMAD Pathway Is Modulated by miR-26b-5p: Another Piece in the Puzzle of Chronic Lymphocytic Leukemia Progression
2022 · Maria Elena Marquez, Sandra Sernbo, et al. · Cancers · 10
PDF
Targeting S100A9-mediated inflammation: a novel therapeutic approach for CLL
2025 · Angimar Uriepero-Palma, Maria Elena Márquez, et al. · Blood Advances · 7
PDF
Optimization of In Vitro Th17 Polarization for Adoptive Cell Therapy in Chronic Lymphocytic Leukemia
2024 · Wael Gamal, Melanie Mediavilla-Varela, et al. · International Journal of Molecular Sciences · 3
Myelodysplasia From Valproic Acid Resolved by Cessation
2026 · Chidiebube Ugwu, Angimar Uriepero Palma, et al. · Case Reports in Hematology · 1
PDF
Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis
2024 · Julio C Chavez, Ariel Grajales, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
PDF
Clinical outcomes in patients with multiple myeloma and antidepressant use: A retrospective cohort study
2025 · Akshay Ratnani, Thitiphan Srikulmontri, et al. · Blood
PDF
Real world outcomes comparing the use of GLP-1 receptor agonists in patients with CML and comorbid obesity: A propensity score matched analysis from global federated health research network
2025 · Arshi Syal, Yajur Arya, et al. · Blood
PDF
Cardiovascular outcomes in CLL patients receiving GLP-1 agonists and BTK inhibitors: A global propensity-matched study
2025 · Angimar Uriepero, Jose Milano, et al. · Blood
PDF
Age-related differences in outcomes and treatment patterns of iron deficiency anemia in patient's with crohn's disease
2025 · Karecia Byfield, Elvis Obomanu, et al. · Blood
Impact of GLP-1 agonists on cardiovascular outcomes in patients with sickle cell anemia: A propensity score matched retrospective cohort study
2025 · Sam King, Swe Swe Hlaing, et al. · Blood
PDF
Real world outcomes analysing the use of glucocorticoids in patients with acute chest syndrome: A propensity score matched analysis from global federated health research network
2025 · Yajur Arya, Arshi Syal, et al. · Blood
PDF
Clinical outcomes of first-line venetoclax-based regimens vs second-generation BTK inhibitors in CLL/SLL: A retrospective cohort study
2025 · Angimar Uriepero, Jose Milano, et al. · Blood
One-year outcomes of daratumumab-based vs. non-daratumumab regimens in AL amyloidosis: A propensity-matched real-world study
2025 · Chidiebube Ugwu, Muluken Megiso, et al. · Blood
PDF
Acalabrutinib vs zanubrutinib as first-line therapy in CLL: A propensity score–matched study
2025 · Angimar Uriepero, Jose Milano, et al. · Blood
Enhancing CAR-T Therapy in CLL By Modulating the Immunosuppressive Tumor Microenvironment: A Novel Approach with Significant Therapeutic Potential
2024 · Angimar Uriepero Palma, Melanie Mediavilla Varela, et al. · Blood
Abstract 4843: Characterization of T-cell metabolic defects in chronic lymphocytic leukemia preclinical model
2023 · Wael Gamal, Melanie Mediavilla-Varela, et al. · Cancer Research
Metabolic Abnormalities Associated with T-Cell Exhaustion in CLL Eµ-TCL1 Murine Model
2022 · Wael Gamal, Melanie Mediavilla-Varela, et al. · Blood
Targeting Inflammatory Pathways to Reverse Immunosuppressive Tumor Microenvironment in Chronic Lymphocytic Leukemia
2022 · Angimar Uriepero, Melanie Mediavilla-Varela, et al. · Blood
Abstract 5496: Efficacy and immune profiling of PI3K delta inhibitor zandelisib (ME-401) in a preclinical chronic lymphocytic leukemia (CLL) model
2022 · Kamira Maharaj, Melanie Mediavilla-Varela, et al. · Cancer Research
Efficacy of Vecabrutinib Treatment in a Murine Model of Sclerodermatous Graft-Versus-Host-Disease
2021 · Kamira Maharaj, Melanie Mediavilla-Varela, et al. · Blood
Works count: 26
Citation count: 145
H-index: 7
I10-index: 6
Year
Topic
Type